📌 𝐅𝐨𝐥𝐥𝐨𝐰 𝐨𝐧 𝐈𝐧𝐬𝐭𝐚𝐠𝐫𝐚𝐦:- [ Ссылка ]
📌𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗧𝗲𝗹𝗲𝗴𝗿𝗮𝗺 𝗖𝗵𝗮𝗻𝗻𝗲𝗹 𝗛𝗲𝗿𝗲:- [ Ссылка ]
📌𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲 𝗧𝗼 𝗠𝘆 𝗠𝗮𝗶𝗹𝗶𝗻𝗴 𝗟𝗶𝘀𝘁:- [ Ссылка ]
Favipiravir – Favipiravir is an RNA polymerase inhibitor that is available in some Asian countries for the treatment of influenza, and it is being evaluated in clinical trials for the treatment of COVID-19 in the United States. In a study of patients with non-severe disease including oxygen saturation greater than 93 percent, the use of favipiravir was associated with faster rates of viral clearance (median time to clearance 4 versus 11 days and more frequent radiographic improvement in 91 versus 62 percent by day 14 compared with lopinavir-ritonavir. However, other therapies were administered in this non-randomized, open-label study, so the results should be interpreted with caution given potential confounders.
Favipiravir is currently under investigation for use in the treatment of coronavirus disease 2019 (COVID-19) (see ClinicalTrials.gov). At this time, safety and efficacy have not been established.
#COVID19medicine #favipiravir #coronavirusmedicine #covid19treatment #covid19 #managementofcovid19
Favipiravir : Corona Virus Hot Update | COVID 19 Medicine
Теги
favipiravir for coronafavipiravirfavipiravir tablets 200 mgfavipiravir india hindifavipiravir tabletfavipiravir glenmarkfavipiravir mechanism of action in covidfavipiravir medicine glenmarkcovid19 favipiravirfavipiravir covid resultsfavipiravir india trialsfavipiravir treatment for covid19medicine for covid19 favipiravirfavipiravir for coronavirus indiafavipiravir for coronavirusfavipiravir for corona viruscovid 19 and favipiravircovid-19corona